{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:32:35Z","timestamp":1763544755970},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"College of Pharmacy NEOMED Priority Project"},{"name":"NIH\/NEI","award":["EY022358"],"award-info":[{"award-number":["EY022358"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejpb.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T13:07:30Z","timestamp":1466341650000},"page":"56-66","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug"],"prefix":"10.1016","volume":"107","author":[{"given":"Dharani","family":"Manickavasagam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wehrung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh A.","family":"Chamsaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachida","family":"Bouhenni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel D.","family":"Crish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Joy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses O.","family":"Oyewumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.06.012_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pharmaceutics4010197","article-title":"Ocular drug delivery for glaucoma management","volume":"4","author":"Gooch","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2016.06.012_b0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma","volume":"25","author":"Lavik","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2016.06.012_b0015","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2016.06.012_b0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.06.012_b0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma for a month","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.06.012_b0030","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1016\/j.biomaterials.2003.10.075","article-title":"Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment","volume":"25","author":"Wang","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.06.012_b0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.colsurfb.2013.06.047","article-title":"Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye","volume":"112","author":"Xu","year":"2013","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2016.06.012_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2011.05.047","article-title":"In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment","volume":"415","author":"Natu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.06.012_b0045","first-page":"895013","article-title":"Critical assessment of implantable drug delivery devices in glaucoma management","volume":"2013","author":"Manickavasagamand","year":"2013","journal-title":"J. Drug Del."},{"key":"10.1016\/j.ejpb.2016.06.012_b0050","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1021\/mz3002947","article-title":"Photoinduced polymer chain scission of alkoxylphenacyl based polycarbonates","volume":"1","author":"Sun","year":"2012","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.ejpb.2016.06.012_b0055","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/jps.23510","article-title":"Biocompatibility and in vivo tolerability of a new class of photoresponsive alkoxylphenacyl-based polycarbonates","volume":"102","author":"Wehrung","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.06.012_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-6-4","article-title":"Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons","volume":"6","author":"Lambert","year":"2011","journal-title":"Mol. Neurodegeneration"},{"key":"10.1016\/j.ejpb.2016.06.012_b0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajo.2008.08.005","article-title":"Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model","volume":"147","author":"Ma","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2016.06.012_b0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2016.06.012_b0075","first-page":"S20","article-title":"Current management of glaucoma and the need for complete therapy","volume":"14","author":"McKinnon","year":"2008","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejpb.2016.06.012_b0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1021\/mz3002947","article-title":"Photoinduced polymer chain scission of alkoxyphenacyl based polycarbonates","volume":"1","author":"Sun","year":"2012","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.ejpb.2016.06.012_b0085","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ejpb.2014.07.011","article-title":"Formulation and photoirradiation parameters that influenced photoresponsive drug delivery using alkoxylphenacyl-based polycarbonates","volume":"88","author":"Wehrung","year":"2014","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"key":"10.1016\/j.ejpb.2016.06.012_b0090","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1166\/jnn.2012.5789","article-title":"Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery","volume":"12","author":"Wehrung","year":"2012","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejpb.2016.06.012_b0095","doi-asserted-by":"crossref","first-page":"e24513","DOI":"10.1371\/journal.pone.0024513","article-title":"Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye","volume":"6","author":"Natarajan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.06.012_b0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/0975-1483.71623","article-title":"Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system","volume":"2","author":"Prabhu","year":"2010","journal-title":"J. Young Pharm.: JYP"},{"key":"10.1016\/j.ejpb.2016.06.012_b0105","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1208\/s12249-011-9701-3","article-title":"Biodegradable ocular inserts for sustained delivery of brimonidine tartrate: preparation and in vitro\/in vivo evaluation","volume":"12","author":"Aburahmaand","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2016.06.012_b0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1208\/s12249-011-9643-9","article-title":"Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation","volume":"12","author":"Maiti","year":"2011","journal-title":"AAPS PharmSciTech."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116302211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116302211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T23:22:10Z","timestamp":1568071330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116302211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":22,"alternative-id":["S0939641116302211"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.06.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}